584620-U

Ascentis^® Express 160 Å Phenyl-Hexyl (2.7 μm) HPLC Columns

L × I.D. 15 cm × 4.6 mm, HPLC Column

• Synonym(e): Ascentis^® Express 160 Å Phenyl-Hexyl, 2.7 μm HPLC Column
• UNSPSC-Code: 41115700
• NACRES: SB.52

Eigenschaften

• product name: Ascentis^® Express 160 Å Phenyl-Hexyl, 2.7 μm HPLC Column, column L × I.D. 15 cm × 4.6 mm
• Materialien: stainless steel column
• Agentur: suitable for USP L11
• Produktlinie: Ascentis^®
• Leistungsmerkmale: endcapped
• Verpackung: 1 ea of
• Kennzeichnungsgrad: 4.7% Carbon loading
• Methode(n): HPLC: suitable; LC/MS: suitable
• Säule L × ID: 15 cm × 4.6 mm
• Oberflächenbereich: 90 m²/g
• Matrix: Fused-Core^® particle platform; superficially porous particle
• Aktive Matrixgruppe: Phenyl-Hexyl (dimethylphenyl-hexylsilane) bonding phase
• Partikelgröße: 2.7 μm
• Porengröße: 160 Å pore size
• operating pH range: 2-9
• Trenntechnik: reversed phase

Beschreibung

Allgemeine Beschreibung

Ascentis^® Express 160 Å Phenyl-Hexyl is a high-speed, high-performance liquid chromatography column based on a 160Å Fused-Core^® particle design. The particle provides a thin porous shell of high-purity silica surrounding a solid silica core. This particle design exhibits very high column efficiency for high molecular weight solutes (up to 20 kDa) due to the shallow diffusion paths in the 0.5 μm thick porous shell and the small overall particle size of 2.7 μm. The endcapped, phenyl-hexyl bonded phase provides a stable, reversed phase packing with a pore structure and pore size that is optimized for reversed-phase HPLC separations of peptides and polypeptides, using typical acidic mobile phases favored for proteomic applications.

Hinweis zur Analyse

Target analytes include electron-poor molecules, aromatic or unsaturated compounds (ketones, nitriles, alkenes), as well as peptides and polypeptides < 20 kDa.

Rechtliche Hinweise

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.